Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630nm) and a metal-halide lamp (600 to 740nm) for treatment of Bowen's disease

Photodermatology Photoimmunology and Photomedicine

Volumn 28, Issue 3, 2012, Pages 142-146

  Mizutani, Kentaro ^a   Akita, Yoichi ^a   Yanagishita, Takeshi ^a   Kimura, Makoto ^b   Tanaka, Tohru ^c   Kinoshita, Yumi ^a   Nakano, Aki ^a   Tamada, Yasuhiko ^a   Matsumoto, Yoshinari ^a   Watanabe, Daisuke ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^c SBI Pharmaceuticals Co   (Japan)

Author keywords

5 aminolevulinic acid; Bowen's disease; Clinical trial; Light source; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; HALIDE; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BOWEN DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREAM; EXCIMER LASER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IRRADIATION; JAPANESE; LIGHT EXPOSURE; MALE; METAL HALIDE LAMP; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE; SKIN PIGMENTATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BOWEN'S DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84860457240     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2012.00658.x     Document Type: Article

References (17)

1. Morton CA, McKenna KE, Rhodes LE. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Br J Dermatol 2008; 159: 1245-1266.
2. Calin MA, Diaconeasa A, Savastru D, Tautan M. Photosensitizers and light sources for photodynamic therapy of the Bowen's disease. Arch Dermatol Res 2011; 303: 145-151.
3. Morton CA, Brown SB, Collins S etal. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567.
4. Kobayashi M, Nakaseko H, Akita Y etal. A study of treatment outcome results after using topical 5-aminolaevulinic acid-based photodynamic therapy on superficia, cutaneous carcinomas. Jpn J Dermatol 2002; 112: 1577-1583.
5. Kim YJ, Kang HY, Lee ES etal. Photodynamic therapy for treatment of Bowen's disease. Korean J Dermatol 2007; 45: 237-241.
6. Matsumoto Y, Akita Y, Nakaseko H etal. Clinical responses to topical photodynamic therapy of actinic keratoses, Bowen's disease and non-oncological disease in Japan. Laser Therapy 2010; 19: 159-166.
7. Peng Q, Warloe T, Berg K etal. 5-aminolevulinic acid-based photodynamic therapy, clinical research and future challenges. Cancer 1997; 79: 2282-2308.
8. Theodossiou T, MacRobert AJ. Comparison of the photodynamic effect of exogenous photoprotoporphyrin and protoporphyrin IX on PAM 212 murine keratinocytes. Photochem Photobiol 2002; 76: 530-537.
9. Konig K, Schneckenburger H, Ruck A, Steiner R. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B 1993; 18: 287-290.
10. Gudgin Dickson EF, Pottier RH. On the role of protoporphyrin IX photoproducts in photodynamic therapy. J Photochem Photobiol B 1995; 29: 91-93.
11. Charlesworth P, Rruscott TG. The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). J Photochem Photobiol B 1993; 18: 99-100.
12. Kubat P, Zelinger Z, Jirsa M. The effect of the irradiation wavelength on the processes sensitized by protoporphyrin IX dimethyl ester. Radiat Res 1997; 148: 382-385.
13. Kimura M, Kosobe T, Hanada K etal. Development of optical light source using metal halide lamp for PDD and PDT. The Journal of Japan Society for Laser Medicine 2003; 24: 101-108.
14. Moan J, Iani V, Ma LW. Choice of the proper wavelength for photochemotherapy. SPIE-Proceedings, 1996; 2625: 544-549.
15. Nakano A, Tamada Y, Watanabe D etal. A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and histological severity. Photodermatol Photoimmunol Photomed 2009; 25: 37-40.
16. Nakaseko H, Kobayashi M, Akita Y etal. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol 2003; 148: 122-127.
17. Utsuki S, Oka H, Tanizaki Y etal. Experimental photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX for malignant glioma. The Kitasato Medical Journal 2006; 36: 47-51.